Open AccessAre anti-vascular endothelial growth factor drugs the panacea for all diabetic retinopathy patients?
Author(s) -
Jacob Koshy
Publication year - 2013
Publication title -
journal of clinical ophthalmology and research
Language(s) - English
Resource type - Journals
eISSN - 2320-3900
pISSN - 2320-3897
DOI - 10.4103/2320-3897.112183
Subject(s) - medicine , bevacizumab , diabetic retinopathy , vascular endothelial growth factor , intravitreal administration , adverse effect , panacea (medicine) , diabetes mellitus , ophthalmology , vegf receptors , chemotherapy , endocrinology , pathology , retinal , alternative medicine
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom